Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Ugwumba Chidozie10% Owner |  CLNNClene Inc.Open-market sale | SELL | $21K 4,278 sh | Apr 1, 2026 |
| 12 | Brady James AloysiusDirector |  XERSXeris Biopharma Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $60K 10.8K sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 790 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 9 | Savitz RyanEVP, CFO & CBO |  DNTHDianthus Therapeutics, Inc. /DE/Open-market sale · 10b5-1 plan | SELL | $119K 1,485 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Savitz RyanEVP, CFO & CBO | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $65K 800 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Savitz RyanEVP, CFO & CBO | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $196K 2,366 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Savitz RyanEVP, CFO & CBO | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $109K 1,390 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 8 | Bird Justin ChristopherExecutive Vice President |  SRESEMPRAOpen-market sale · 10b5-1 plan | SELL | $109K 1,128 sh | Apr 1, 2026 traded Apr 1, 2026 |
| 8 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 4,000 sh | Apr 1, 2026 traded Apr 1, 2026 |
| 3 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 4,000 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 3 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $38K 4,000 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 1 | Pena Fernando AustinDirector, President |  BXMTBLACKSTONE MORTGAGE TRUST, INC.Open-market sale · 10b5-1 plan | SELL | $31K 1,666 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 50 | Morgan RachelEVP General Counsel |  NXSTNEXSTAR MEDIA GROUP, INC.Open-market sale | SELL | $668K 3,127 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 50 | Weaver Robert S.EVP, Government Relations | NXSTNEXSTAR MEDIA GROUP, INC. Open-market sale | SELL | $399K 1,872 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 47 | Lamattina John LDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale | SELL | $434K 2,161 sh | Mar 31, 2026 traded Mar 6, 2026 |
| 44 | Degner DennisChief Executive Officer & Pres |  RRCRANGE RESOURCES CORPOpen-market sale | SELL | $693K 15.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 40 | Preston Tracy MEVP, CLO & Corporate Secretary |  MMacy's, Inc.Open-market sale | SELL | $49K 2,736 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 39 | Bron OlivierCEO, Bloomingdale's | MMacy's, Inc. Open-market sale | SELL | $54K 3,051 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 39 | Weitman GarySee Remarks | NXSTNEXSTAR MEDIA GROUP, INC. Open-market sale | SELL | $214K 1,005 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 36 | McDowell Erin WSVP & General Counsel | RRCRANGE RESOURCES CORP Open-market sale | SELL | $396K 8,250 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 35 | Manor SagitCFO |  NYAXNayax Ltd.Open-market sale | SELL | $69K 1,252 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 35 | Szabo ShandellDirector |  MGYMagnolia Oil & Gas CorpOpen-market sale | SELL | $375K 11.7K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 33 | Manning MeredithChief Commercial Officer |  SLNOSOLENO THERAPEUTICS INCOpen-market sale | SELL | $146K 4,864 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 33 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Open-market sale | SELL | $128K 4,256 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 32 | Furman Carly LisanneCEO NAYX North America | NYAXNayax Ltd. Open-market sale | SELL | $17K 313 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 32 | Tepper OrenCRO | NYAXNayax Ltd. Open-market sale | SELL | $3,991 74 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 30 | Garagic DenisCHIEF TECHNOLOGY OFFICER |  PDYNPalladyne AI Corp.Open-market sale | SELL | $84K 15.1K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 29 | Manning MeredithChief Commercial Officer | SLNOSOLENO THERAPEUTICS INC Open-market sale | SELL | $65K 2,100 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 29 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $356K 44.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 29 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Open-market sale | SELL | $57K 1,838 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 27 | Sonne StephenCHIEF LEGAL OFFICER | PDYNPalladyne AI Corp. Open-market sale | SELL | $19K 3,471 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 27 | Thatcher TrevorCHIEF FINANCIAL OFFICER | PDYNPalladyne AI Corp. Open-market sale | SELL | $17K 3,030 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 26 | Manning MeredithChief Commercial Officer | SLNOSOLENO THERAPEUTICS INC Open-market sale | SELL | $18K 558 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 26 | Lentell EricChief Legal & Strategy Officer |  ACHRArcher Aviation Inc.Open-market sale · 10b5-1 plan | SELL | $268K 50.0K sh | Mar 31, 2026 traded Mar 26, 2026 |
| 26 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Open-market sale | SELL | $15K 488 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 25 | Tirman MatthewPresident |  SATLSatellogic Inc.Open-market sale | SELL | $49K 9,499 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 24 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $332K 68.0K sh | Mar 31, 2026 traded Mar 31, 2026 |
| 21 | Lozinski Jeffrey William10% Owner |  KSEZKinetic Seas Inc.Open-market sale | SELL | $3,000 100.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 20 | Lentell EricChief Legal & Strategy Officer | ACHRArcher Aviation Inc. Open-market sale · 10b5-1 plan | SELL | $265K 50.0K sh | Mar 31, 2026 traded Mar 27, 2026 |
| 19 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $220K 16.3K sh | Mar 31, 2026 traded Mar 27, 2026 |
